Related Stories
NHS sues drug firms 'for 100m'
Key Excerpts from Article on Website of BBC News
Posted: November 11th, 2006
http://news.bbc.co.uk/1/hi/health/3832291.stm
The NHS is seeking at least 100m compensation from two drug companies who it alleges "fixed" the price of an ulcer drug in the late 1990s. The allegations relate to the sale and supply of ranitidine between 1997 and 2000. The NHS's Counter Fraud Service [CFS]...is currently investigating similar concerns in regard to around 30 other drugs. As in any case where a drug comes off patent, the NHS expected its price to fall, but this did not happen with ranitidine. The investigation into why this failed to happen has led to the High Court action against Generics, a subsidiary of the German pharmaceutical company Merck, and the British arm of the Indian company Ranbaxy. The CFS estimates that the NHS could have lost out on at least 100m, and possibly as much as 110m. It has already said it will sue seven companies over the sale of common medicines including warfarin and penicillin-based drugs.
Related Stories
Latest News
Key News Articles from Years Past
